The Company provides healthcare information technology solutions and pharmacy benefit management services to the pharmaceutical supply chain in the US and Canada.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
With the recent market moodiness, I was poking around the screener, taking a look at companies with a high cash/share value. The idea was to find high-growth, low-debt, high-performing companies that are well insulated from a double-dip recession, or could use their excess cash for either stock repurchases, or acquisitions, should the recession drag on, or turn worse (double-dip, or full-blown depression). The screen I used was:
Cash Per Share: $8.00+
Rev. Growth Rate (last 3 Yrs): 20.00+
EPS Growth Rate (last 3 Yrs): 8.00+
Current Ratio: 2.00+
Interestingly, I got a lot of past Rule Breaker picks in the list, and a few new ones I've never come across, including this one. Summary: this company is well insulated against risk, and has a solid, three-year track record.